Isofol Medical AB (publ) (FRA:5IU)

Germany flag Germany · Delayed Price · Currency is EUR
0.0500
-0.0020 (-3.85%)
At close: Jan 27, 2026
-71.13%
Market Cap17.84M -43.7%
Revenue (ttm)n/a
Net Income-4.93M
EPS-0.03
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0500
Previous Close0.0520
Day's Range0.0500 - 0.0500
52-Week Range0.0465 - 0.1868
Betan/a
RSI47.34
Earnings DateFeb 18, 2026

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2008
Employees 6
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5IU
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements